Current role
Biotechnology · Healthcare
Board Member
2024-06-24–present
Sarah Boyce
Equibles does not estimate personal net worth.
Get an email with a short summary when Contineum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CTNM alertsAbout Sarah Boyce
Sarah Boyce is recorded as Board Member at Contineum Therapeutics, Inc. (CTNM). The newest filing on record that lists Sarah Boyce as Board Member at Contineum Therapeutics, Inc. (CTNM) is dated April 30, 2026. Contineum Therapeutics, Inc. reported in an 8-K filed June 24, 2024 that Sarah Boyce was appointed member of its Board, effective June 24, 2024. Contineum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Contineum Therapeutics, Inc. includes Carmine N. Stengone (CEO and Board Member), Peter T. Slover (CFO), John S. Healy (General Counsel) and 6 others.
“On June 21, 2024, the board of directors (the "Board") of Contineum Therapeutics, Inc. (the "Company") appointed Sarah Boyce as a member of its Board, effective June 24, 2024.”
Affiliation history
-
Current
2024-06-24–present
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Contineum Therapeutics, Inc.
- Carmine N. Stengone CEO, Board Member
- Peter T. Slover CFO
- John S. Healy General Counsel
- Diego Miralles Board Member
- Diego Miralles, M.D. Board Member
- Lori M. Lyons-Williams Board Member
- Olivia Ware Board Member
- Todd Brady Board Member
- Troy Ignelzi Board Member